RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Oct 30, 2023--Evecxia Therapeutics, Inc., the leader in serotonin synthesis amplification to treat neuropsychiatric disorders, today announced the appointments of Allan L. Shaw and Elliot Ehrich, MD to its Board of Directors, bringing with them ...
BEIJING--(BUSINESS WIRE)--Oct 26, 2023--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the Phase III registrational trial of the CompanyĢƵ BTK ...
PORTLAND, Ore. (AP) — What authorities describe as an off-duty pilot's <a href="https://apnews.com/article/alaska-airlines-safety-security-3a86194cccae802341243c77ea0d95ee">attempt to shut down the engines</a> of a Horizon Air flight with more than 80 people on ...
RICHMOND, Calif.--(BUSINESS WIRE)--Oct 26, 2023--BioAge Labs, Inc., (“BioAge”), a clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced plans to initiate a Phase 2 trial of its oral apelin ...